Latest Antibody Stories
Study indicates potential for TauC3 to be disease-modifying. Englewood Cliffs, New Jersey (PRWEB) January 16, 2014 Intellect Neurosciences, Inc.
OXFORD, England and SAN JOSE, California, January 15, 2014 /PRNewswire/ -- Oxford BioTherapeutics, an international biotechnology company developing antibody-drug conjugates
PASADENA, Calif., Jan.
- The OSU study, supported by Bayer and published in Parasites & Vectors, demonstrates heat treatment of feline serum samples prior to testing dramatically improved sensitivity of antigen tests
SAN DIEGO, Jan.
BREDA, The Netherlands and GHENT, Belgium, January 13, 2014 /PRNewswire/ -- Enters into pilot research agreement with Boehringer Ingelheim arGEN-X,
SAN DIEGO, Jan. 10, 2014 /PRNewswire/ -- Sorrento Therapeutics, Inc.
First-in-class program for the treatment of atopic dermatitis and allergic diseases SAN DIEGO, Jan.
SAN FRANCISCO, Jan.
Earlier amyloid-beta assemblies may be one of the most important causes of Alzheimer's disease.
- A person who stands up for something, as contrasted to a bystander who remains inactive.
- One of the upright handlebars on a traditional Inuit sled.
More Images (4 images) »